Renaissance Technologies - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 233 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$39,657
-11.8%
1,438,422
-3.9%
0.07%
+4.6%
Q2 2023$44,979
-10.9%
1,496,322
+7.4%
0.06%
-3.0%
Q1 2023$50,487
+12.3%
1,393,522
+10.6%
0.07%
+8.1%
Q4 2022$44,963
-99.9%
1,260,522
-1.5%
0.06%
+1.6%
Q3 2022$43,336,000
+7.3%
1,280,222
-8.4%
0.06%
+27.1%
Q2 2022$40,402,000
+0.5%
1,397,022
+12.3%
0.05%
+2.1%
Q1 2022$40,191,000
+11.2%
1,243,522
+0.4%
0.05%
+4.4%
Q4 2021$36,133,000
-2.4%
1,239,122
-10.8%
0.04%
-6.2%
Q3 2021$37,035,000
-20.7%
1,388,622
-8.4%
0.05%
-17.2%
Q2 2021$46,684,000
+1.3%
1,516,222
-13.9%
0.06%
+1.8%
Q1 2021$46,083,000
-1.0%
1,760,222
-4.8%
0.06%
+11.8%
Q4 2020$46,534,000
+19.5%
1,849,522
-1.0%
0.05%
+30.8%
Q3 2020$38,940,000
+2.9%
1,868,500
+17.3%
0.04%
+18.2%
Q2 2020$37,829,000
+133.1%
1,592,800
+76.5%
0.03%
+106.2%
Q1 2020$16,231,000
-25.7%
902,200
-2.1%
0.02%
-5.9%
Q4 2019$21,848,000
+41.4%
921,100
+63.8%
0.02%
+30.8%
Q3 2019$15,449,000
-22.7%
562,200
-7.0%
0.01%
-27.8%
Q2 2019$19,993,000
+23.4%
604,200
+30.7%
0.02%
+20.0%
Q1 2019$16,199,000
+42.0%
462,300
+34.6%
0.02%
+25.0%
Q4 2018$11,411,000
-51.6%
343,500
-26.6%
0.01%
-50.0%
Q3 2018$23,559,000
-64.8%
467,900
-60.6%
0.02%
-33.3%
Q2 2018$66,858,000
+380.7%
1,188,390
+291.3%
0.04%
+140.0%
Q1 2018$13,909,000
+1237.4%
303,700
+1063.6%
0.02%
+1400.0%
Q4 2017$1,040,000
-40.7%
26,100
-79.1%
0.00%
-75.0%
Q3 2015$1,755,000
-10.1%
125,100
+8.8%
0.00%0.0%
Q2 2015$1,953,000
+49.8%
115,000
-26.8%
0.00%
+33.3%
Q4 2014$1,304,000
+308.8%
157,049
+327.9%
0.00%
+200.0%
Q3 2014$319,00036,7000.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders